Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Near-term fundamental events that will propel stock price gains:
1) around 10/15-3Q revenues announcement. Look for continuation of massive
growth.
2) early November-announcement for uplisting to NASDAQ
3) around 11/15 - 10Q
4) December and following - JV's and Partnerships on new products and biz
activities brought in by 2 new billionaire
hedgefund investors. They didn't put up their
money for anything less than spectacular
returns.
CVLB's prospects are exceptional in an exceptional nascent industry.
OPPORTUNITY!
It is up $.035 today you fool. When someone keeps posting lies that NO ONE believes, he is probably insane. Find another site. Wea are all riding this to multiple dollar prices.
The charts AND the fundamentals align for a runop above $2.00 near term. Next resistance is $1.80 which should be broken by Friday. Around Oct 15 revenues will be announced. CVLB will show accelerating sales growth. Uplisting to NASDAQ should come Nov early. Should hit @2.50 after revenue announcement and $3.50 after uplisting. Then 3rd Q will show cross over to profits, new products coming, maybe significant business partnerships or JV's. This company has the infrastructure, the marketing horses and now with new billionaire hedgefund investors, the contacts to make rain!.. $4.50 in six months.
That was before they started racking up revenue growth in excess of 250%.
This is usually a strong afternoon closer. Looks to close mid $1.60's
I believe the seller was an investor about 6 months ago who converted to common and is selling. He is reputed to have promised the CEO to hold for a year but apparently is a crumb. He sold tons after the price ho
it $2.00 and drove price to $1.00. He has to be close to zero by now.
Who or what is WDCO?
I agree with your chart analysis. Fundamentals will come into play now to resolve the chart to the upside. Anticipation of uplisting, continuing rapid growth, 2 billionaire hedgefund investors with superlative track records, new products coming on stream.
IMO $1.50 is the next stop but it will be short lived. We will see $2.50 by the time the uplisting occurs. When it trades on NASDAQ a surge in demand for this new telemedicine future giant will propel price to $3.50 fairly quickly.
This, of course is speculation but speculation with strong factual support.
I agree with your chart analysis. Fundamentals will come into play now to resolve the chart to the upside. Anticipation of uplisting, continuing rapid growth, 2 billionaire hedgefund investors with superlative track records, new products coming on stream.
IMO $150 is the next stop but it will be short lived. We will see 42.50 by the time the uplisting occurs. When it trades on NASDAQ a surge in demand for this new telemedicine future giant will propel price to $3.50 fairly quickly.
This, of course is speculation but speculation with strong factual support.
Revenue announcement around Oct 16 likely to show consistent massive growth as warrant conversion $ has been deployed in increased marketing that will fuel massive growth. (Rex MD now on talk radio.) This will be followed up with uplist to NASDAQ probably Nov. Watch it soar!!!
May be quiet until 10/16 as people trade around small moves.
PMUNCH, Thanks for your hard work in bringing CVLB info up to date. Looks great.
Seller trying to contain upward price movement over the past month is almost out. Only 80,000 shares and then to $.40. Next resistance is around $.50. Company should be even higher in 2 months, based on growth. This is a L-T hold. 2 more product launches this Q, after strong PDF launch. Cash position building, marketing execution intensifying. Revenues surging. This could be perfect storm to propel a multi $ s/p.
You are correct. Dan is very accessible. Always responds to calls. He and the Otto and the new investor are moving this company forward. Investors should ignore Suvarov who is really Drew Currah, sit tight and add to holdings as successive future announcements reveal the attainment of development plans.
Suvorov (actually Drew Currah) Big mouth, no facts, no integrity. Coming soon to a corrections facility near you.
News Release 8/29:
LAS VEGAS, Aug. 29, 2017 (GLOBE NEWSWIRE) -- Envoy Group Corp.(ENVV) (the “Company” or “Envoy”), a digital currency and Blockchain technology company, today issued a statement to shareholders in regards to its ongoing operations, its plans to monetize opportunities in the cryptocurrency sector and its SEC reporting status.
“Recently, there may have been confusion regarding Envoy's required financial reports and current status of the company,” stated Harp Sangha, Envoy Group’s Chief Executive Officer. “At present, Envoy Group is completely up to date on all required SEC financial reports. On the business side, we have made tremendous progress in ramping up our operations, commencing commercialization and creating a plan to increase revenue.”
Over the past year, the price of Bitcoin surged more than 600%, while Ethereum has soared more than 1,000% in the last six months alone. These extraordinary increases in the value of Blockchain technology-based crypto-currency assets, aligned with the increasing involvement of major financial firms, such as Goldman Sachs and JP Morgan, demonstrate that crypto-currencies are now entering mainstream acceptance, and validates our growth strategy.
On Monday, August 28, OTC Markets removed the caveat emptor it placed on Envoy Group(ENVV) stock.
https://www.otcmarkets.com/stock/ENVV/quote
Recent business highlights:
Successfully tested several Graphic Processor Units (GPUs) at the BitReturn processing facility
Current mining operations have yielded gross profits in excess of 45%
Received shipment of BitReturns’ first large block of cryptocurrency mining hardware
Added over 500 Nvidia revenue producing GPUs to mining efforts
Implemented a new operating system that increases efficiency by centrally managing all mining hardware reducing labor costs and improving scalability
Revenue Creation Plan :
In addition to the cryptocurrencies currently being profitably mined we are reviewing the addition of DASH ASIC miners to our mining centre as well as to diversify and greatly increase our revenue stream by bringing on traditional datacenter clients into the existing facility.
Opportunities in Cryptocurrency Sector :
Envoy is currently reviewing several transformative Blockchain applications for asset management and within the financial sector to facilitate crypto to fiat currency transactions.
To read Envoy Group’s most recent 10K Annual Report filing for the period ended April 30, 2017, please visit: https://www.sec.gov/cgi-bin/browse-edgar?company=envoy+group&owner=exclude&action=getcompany
About Envoy Group, Corp.(ENVV)
Envoy Group, Corp. (ENVV) is a digital currency and Blockchain technology company. BitReturn, a division of the Envoy Group Corp.(ENVV), has first targeted a high positive cash flow method of Mining of Digital Currencies that has been de-risked by employing the most effective Graphic Processor (GPU) technology and BitReturn’s secure Tier3 (T3) facility in Kamloops, B.C. Hundreds of 7 to 13 GPU arrays will be working 24/7 within the climate controlled facility. Mining of Digital Currencies will be constantly directed to which currencies provide maximized profitability. New digital coins drop into the world every 10 minutes and BitReturn will be there to catch them. Block Chain is an incorruptible publically distributed digital ledger that allows for transparent and secure validation of online information.
For more information, please visit: http://bitreturn.com
I noticed that as well and I even called a friend of mine who is an IMMD investor. We concluded that it was not a company related move because it was so obvious as it occurred in the last few minutes. We think it was probably a shareholder who noticed that the bid-ask spread had widened to $.04 and the person saw an opportunity to post a larger gain for the day. What is significant is that the price rose to $.50 due to market forces.
Continuing with your false dialog Drew Currah? Massive sales increases, proven efficacy of their marketing group platform, $1.1mm in q sales are NOT fluff. The only fluff on this board is in your mind.
Here is the whole release. Marketing platform is performing very well. Costs driven down and margins widen. This what we patient shareholders have been waiting for.
MT. KISCO, N.Y., July 18, 2017 (GLOBE NEWSWIRE) -- Immudyne, Inc.(IMMD) (“Immudyne” or the “Company”), a leader in the development and marketing of OTC health and wellness products addressing large unmet needs, announced today the Company’s preliminary financial results for the fiscal second quarter ended June 30, 2017. The Company expects to report net revenue was approximately $1.1 million, an increase of approximately 150% from the previous quarter. Revenue growth in the second quarter was led by the Shapiro MD product line, sold through Immudyne’s majority owned subsidiary, Immudyne PR, LLC. Immudyne’s strategic additive business also increased approximately 74% from the previous quarter.
“Although it’s our current policy not to publicly project future revenue, we will simply say that we are very pleased with our sales performance in the second quarter, and look forward to the remainder of 2017 and beyond,” stated Mark McLaughlin, CEO of Immudyne(IMMD). “Immudyne and our PR subsidiary have built a highly scalable infrastructure and a world-class marketing team that is beginning to show promising traction across multiple brands. Our restructuring effort that we began late last year is clearly starting to pay off.”
The Company estimates that it had approximately $700,000 in cash, near-term receivables and merchant reserves as of July 15, 2017. Additionally, between April 1, 2017 and July 15, 2017, Immudyne(IMMD) reduced its net liabilities by approximately $200,000.
“The restructuring effort we began in early 2017 is starting to gain traction,” stated Stefan Galluppi, COO of Immudyne. “We’ve internalized most of our media buying, significantly improved our margins, and have created a patented product line that we can roll out globally in a multi-billion-dollar market.”
I'll answer for the self-serving slammer. He states those lies because he is vested in hurting IMMD and killing the rally. He may even be a short seller. I hope he loses his shirt.
Excellent marketing move for IMMD. Amazon is the prime marketing outlet in the world and IMMD has partnered with one of their most powerful players. New hair loss product #1 new release. Sales are surging. See today's N.R. below.
MT. KISCO, N.Y., July 10, 2017 (GLOBE NEWSWIRE) -- ImmuDyne, Inc.(IMMD) (“Immudyne” or the “Company”), a leader in the development and marketing of OTC healthcare products, is pleased to announce Immudyne PR has partnered with MH Caribbean Management, LLC (“MHCM”). MHCM is the owner and operator of an Amazon Store ranked as an Amazon USA top 1000 seller (as per Marketplace Pulse).
Given the importance of Amazon and the preference of many consumers to purchase products through Amazon Prime, partnering with one of the largest and most successful Amazon resellers in the world gives Immudyne PR a big competitive advantage as Shapiro MD continues to capture market share and expands into international markets. In addition to its global reach, Amazon has a global fulfillment infrastructure that fits perfectly into Immudyne’s highly scalable, direct-response business model.
“The Amazon selling platform has become essential for brands large and small seeking to reach the global consumer,” stated Justin Schreiber, President of Immudyne PR. “This partnership provides immediate and lasting benefits for Shapiro MD and future products launched by Immudyne PR. Our customer acquisition costs have decreased, our Amazon sales doubled within the first week, and we’ve been able to offer other features to our customers that are typically restricted on Amazon for new brands.”
In addition to an immediate uptick in sales, Shapiro MD was also awarded the #1 New Release by Amazon in the Hair Regrowth Treatments category.
“We are very pleased with the sales results of the Shapiro MD product line since its launch in mid-May,” stated Mark McLaughlin, Chief Executive Officer of Immudyne. “We expect inventory levels to stabilize in the next two weeks will permit us to continue to scale both on Amazon and through our internal media.”
I stand corrected. You are right, there is much bad Karma and it is closing in on him as we post.
They will probably be requesting delays in the future because of the satisfaction guarantee/return policy, which takes time to analyse. If this indicates initial rollout sales for Shapiro M.D., which seems to be about 2 weeks of sales in Q1, this may be beyond expectations. Must wait for updated info.
I share the frustration with lack of info. I have been a shareholder for 10 years and I even have had conversations with McLaughlin about lack of info and the need for a planned investor information program. McLaughlin's view is that he is not managing a stock price. He is managing and building a company. He detests "puff press releases" and thinks they hurt the reputation of the company. There will be info forthcoming and we wait for those days.
It is simply an exposition of the background and motivation of a dishonest poster. Suvorov is Andrew Currah, who bears malice against McLaughlin for reasons that I have clearly laid out. His nefarious background is quite relevant, because we all should be interested in the credibility of posters. It is only Karma as you state, to the extent that Currah's illicit dealings are being exposed here and his wrongful acts are coming back to haunt him. If you meant that my comments about Currah are acrimonious, you are right. His motivations for slamming IMMD are hateful and self-serving. He has a history of fraudulent acts that have caused him to be banned from trading. He has harmed shareholders of other companies. What, should I not expose him? Should I urge understanding for him?
Andrew, you will need lots of stress pills as he noose tightens around your fraudulent neck. In the near future your illicit actions will result in civil and criminal jeopardy for you and your cohort. I have documented your illicit trading and management past and you cannot deny it or counter it. It is easy to make silly claims, but for you, impossible to mount a credible denial. Here is the link to the securities FINDINGS about you:
http://www.osc.gov.on.ca/documents/en/Proceedings-SOA/soa_20051020_curraha-amend.pdf
This is very relevant, because it does to YOUR credibility, or lack thereof.
Andrew Currah, you are a liar, a stock manipulator, and a hateful slimeball who has a vendetta against McLaughlin because he aggressively pursued getting his money back in a fraudulent private placement engineered by you and Scot Keevil. It is time for people on this board to know your checkered history.
1) You have been barred from trading by the Ontario Security Commission for "Manipulative and Deceptive Trading" while as president of Findore Corp. According the the Commission you and your cohorts used match trades to run the s/p from $.14 to $2.30. You used trades in 13 brokerage accounts to pump this stock by making it appear that volume was multiple times higher than it was, and you dumped your shares, as you made $1,000,000 by screwing other investors. It is the finding of the Commission that you are a stock manipulator. Therefore NOTHING you post is reliable.
2) As an officer of Joshua Gold Corp, an Ontario, Canada company, you failed to file 10K's and Q's for three years and the SEC instituted administrative proceedings against the company. What a hypocrite you are as you slammed McLaughlin for being a few weeks late on IMMD's 10K!
3)You and Scot Keevil executed a bogus private placement for a company called Shining Tree Gold Mine. You took several thousands of dollars from at least 2 New York investors (one of whom is McLaughlin) and NO shares were ever issued.
Someone posted that they do not care about your past. This is why everyone on this board should care. You are a bad person --dishonest, manipulative and unrepentant. You continue your sleazy actions on this board in order to harm McLaughin and the fine company he is building. AND BY THE WAY, EVERYTHING I POSTED IS OBJECTIVE AS EVERYTHING HAS BEEN FACTUAL. I have criticized McLaughlin when it was due, pointed out any deficiencies that should be noted, and continued to study all reports and industry information. One can be a long-term investor and an objective observer. That is the basis of good due diligence, which is the foundation of succesful investing....you DOPE.
The stop was not removed until today. The 10K confirmed a lot of what was announced previously, provided some interesting clarifications, emphasized a lot of the positives such as management's commitment to the company and their performance based compensation, but since it is for the period ending 12/31 it did not reveal anything new. So trying to make an assessment on stock movement on the day a 10k is issued gets you nowhere. Smallcaps move on information. Now that the 10K is filed, the company will be able to issue press releases on revenue growth and execution of their sales and marketing programs.
I am praising IMMD for objective reasons. I know much more about this company than you could ever wish to accumulate in your biased mind. I have been an investor in IMMD for 10 years never sold and continued to accumulate for years starting at $.05.
You are right. I oppose you. I do so because you , Drew Currah, have a vendetta against McLaughlin because he bested you and Keevil in your bogus capital raise for which shares were never issued. He aggressively pursued getting his money back, which cost you and so you are on this feed to hinder IMMD's development. I urge posters to read the history of your posts. You started out with irrational negative claims and gradually tried a faux reasonable approach as I slammed you and exposed your bias.
You are doing the same thing on another iHub site. You and your buddy Keevil were forced out of that company because the new CEO exposed your highly suspected actions which harmed the shareholders.
NOTHING you post is reliable. As time unfolds your game will be exposed more and more. Just watch.
The charts are setting up and are turning positive. Anyone who waits for $.57 to get in is irrational. You may as well rely on a Ouija Board with your level of knowledge. Drew Currah, you just want to put a damper on demand and peoples' views because of your vendetta against McLaughlin (I have previously posted a clear explanation for this vendetta for those who wish to understand Currah's questionable behavior).
If people like the array of products that are supported by research, the tight capital structure and float, the strong marketing and customer service organization, the rapidly growing sales, the lack of debt and overhang, and the executive and scientific organization that is primarily compensated with stock based on performance, then watch for a day or 2. As the charts show more pronounced upward pressure then it is time to wade in.
Waiting for $.57 is just plain dumb!
Well, there was nothing earth shattering in the 10K, because it is now almost 5 months from the close of the year. Shapiro M.D. was launched in April. However, the filing of the 10K clears the way for press releases regarding sales performance and new developments. Also, OTCMarkets still has IMMD as non-reporting and possibly some of the brokerage houses have also not updated their status regarding IMMD. This may have put a damper on share demand.
Announcements are forthcoming and hopefully they will be quite positive.
No, sleazy people like you need to be exposed so you cannot harm others in the future.
You have been demonstrated to be wrong. The 10K is out and it is apparent that the reason was accounting for discounts, returns, etc., as I have stated. I was posting rapidly so I didn't catch the typos, but I will stack my 2 masters degrees and Ph.D. against your meager education. You continue to speak of Fibonacci, when you know nothing about him or his theories, which were an attempt to offer a mathematical for phenomenon observed in NATURE. NOT stock price movements. You are a dope who heard a term and wants to sound intelligent.
You will wind up in jail for what you and Keevil did over at the Canadian mining company and the new gold pump and dump you creeps are promoting. Bye Bye moron!
There were probably many accounting issues which were new for the company as it built new divisions and erected new structures and relationships. Probably will not be repeated as the learning curve has been scaled. I must say, it is a very very well done document.
It is indeed rare to see company executives supporting a company financially. This is a stark contrast to you, Currah, and Keevil whose questionable activities could be described as "looting".
Right. AND this could be impressive.
Take aways from the 10K:
1) Delay probably caused by accounting for discounts, returns, etc, This was the first annual report that required an extensive analysis of their sales policies.
2) Very significant building of marketing infrastructure, which will yield huge continuing results.
3)Key officers, sales and marketing personnel, etc primarily compensated on a performance basis. Just what is desired for a marketing oriented company.
4) Losses due to a) build of marketing effort, b) stock incentive compensation to key personnel in company building roles
5) Margins of 63% due to sales and marketing build and projected expansion throughout 2017. Most companies would leap for joy with 63%!
6) There may be need for a small capital raise unless sales have accelerated in 2017 and continue to accelerate. But the company has been very conservative in preserving their low share count and has relied on loans from officers and small raises in the range of $100k to $200k. Not a major concern
7) Several research efforts ongoing with existing products and new products to build the pipeline. Funded by the researchers. Gotta love how the company does a lot with a little!
There is a lot to like about this. We await announcements on revenue generation. Even moderately positive and the s/p will launch.
No one wants to advice of someone with your checkered background.
The others will be dealt with if they received shares inappropriately or illegally.
Right you are. Currah and Keevil will be embarrassed.
Drew Currah (Suvarov) and Scot Keevil are scared of Dan. Dan will see to it that they are highly negatively impacted for their past outrageous activities in SRSR. That is Currah's focus. He is scared and he is showing it.